TET2 c.1510_1513del ;(p.K504Qfs*28)

Variant ID: 4-106156609-GAAAA-G

NM_001127208.2(TET2):c.1510_1513del;(p.K504Qfs*28)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


Clonal myelopoiesis promotes adverse outcomes in chronic kidney disease.

Leukemia
Dawoud, Ahmed A Z AAZ; Gilbert, Rodney D RD; Tapper, William J WJ; Cross, Nicholas C P NCP
Publication Date: 2022-02

Variant appearance in text: TET2: 1510_1513del; K504Qfs*28
PubMed Link: 34413458
Variant Present in the following documents:
  • 41375_2021_1382_MOESM2_ESM.xlsx, sheet 1
View BVdb publication page



Submicroscopic deletion of 5q involving tumor suppressor genes (CTNNA1, HSPA9) and copy neutral loss of heterozygosity associated with TET2 and EZH2 mutations in a case of MDS with normal chromosome and FISH results.

Molecular Cytogenetics
Hemmat, Morteza M; Chen, Weina W; Anguiano, Arturo A; Naggar, Mohammed El ME; Racke, Frederick K FK; Jones, Dan D; Wang, Yongbao Y; Strom, Charles M CM; Chang, Karl K; Boyar, Fatih Z FZ
Publication Date: 2014

Variant appearance in text: TET2: 1510_1513delAAAA
PubMed Link: 25177364
Variant Present in the following documents:
  • Main text
  • 1755-8166-7-35.pdf
View BVdb publication page